-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
-
Summary
-
Horizon Therapeutics Public Ltd Co quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q1 2011 to Q1 2023.
- Horizon Therapeutics Public Ltd Co Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2023 was -$88.1M, a 19.9% increase year-over-year.
- Horizon Therapeutics Public Ltd Co annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$348M, a 124% decline from 2021.
- Horizon Therapeutics Public Ltd Co annual Net Cash Provided by (Used in) Financing Activities for 2021 was $1.47B, a 62.5% increase from 2020.
- Horizon Therapeutics Public Ltd Co annual Net Cash Provided by (Used in) Financing Activities for 2020 was $905M.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)